The unique association of human lipodystrophy with the MFN2 R707W allele remains unexplained, but transcriptomic analysis suggested that reduced TGFβ signalling warrants further explanation as a potential cause of adipose hyperplasia, while mTOR inhibitors are worthy of testing in models as a potential targeted therapy. Here, MFN2 is linked to lipodystrophy.